Contact Information

Biography

David E. Zimmerman, PharmD, BCCCP, BCEMP, FASHP, originally from Lancaster, PA is an associate professor of pharmacy at Duquesne University School of Pharmacy and emergency medicine (EM) pharmacist at the University of Pittsburgh Medical Center-Mercy Hospital where he established EM pharmacy services. He completed his ASHP-accredited PGY1 pharmacy practice residency at The Johns Hopkins Hospital and PGY-2 Emergency Medicine residency at Maimonides Medical Center. He has served as a Pennsylvania delegate to the ASHP House of Delegates and is a past chair of the Advisory Group on Emergency Medicine for the ASHP Section of Clinical Specialists and Scientists. He currently serves as a content matter expert for the ASHP/ACCP BCEMP Review course and is the chair of the Pennsylvania Society of Health-System Pharmacists Public Relations Committee. He is co-editor and author of the ASHP Publication, Demystifying Drug Dosing in Obese Patients. He serves as an EM preceptor for APPE students, PGY1 pharmacy practice residents, and PGY2 residents and for APPE students in an elective research experience. He is also a member of EMPHARM-NET research Network.

Education

  • PharmD, Philadelphia College of Pharmacy
  • PGY2, Emergency Medicine Residency, Maimonides Medical Center
  • PGY1, Pharmacy Practice Residency, The Johns Hopkins Hospital

Research Interests or Expertise

  • Pain and substance use disorder management in the emergency department
  • Pharmacokinetics in large body weight patients
  • Implementation of pharmacy services

 

 

Profile Information

Book Editor or Chapter Author

  • Zimmerman DE, Shuster M. Opioid Use Disorder in the Critically Ill. Critical Care Self-Assessment Program Book 2 Toxicology and Analgesia. ACCP. 2023;47-72.
  • Taggart K, Patel S, Zimmerman DE. Chapter50: A toxic situation: the roles of pharmacists and poison control centers. In: Covvey JR, Arya V, DiPietro Mager N, Gilman N, Herring M, Ochs L, Waddington L, eds. Public health in pharmacy practice: a casebook. 2nd ed. Geneseo, NY: Milne Open Textbooks; 2021. Accessed September 27, 2021.
  • Guarascio AJ, Amsden JR, Zimmerman DE. Anti-Infective Agents. In: Nemecek BD, Hammond DA, eds. Demystifying Drug Dosing in Renal Dysfunction. American Society of Health-System Pharmacists. Bethesda, MD. 2019: 15-86.
  • Zimmerman DE. Integrating Clinical Practice and Academic Career. Letters from Rising Pharmacy Stars: Advice on creating and advancing your career in a changing profession. Bethesda, MD: American Society of Health-System Pharmacists; 2016: 145-9.
  • Zimmerman DE. Critical Care. In: Shank BR, Zimmerman DE, eds. Demystifying Drug Dosing in Obese Patients. Shank BR, Zimmerman DE (ed). American Society of Health-System Pharmacists. Bethesda, MD. 2016: 77-96.
  • Zimmerman DE. Antiepileptics. In: Shank BR, Zimmerman DE, eds. Demystifying Drug Dosing in Obese Patients. Shank BR, Zimmerman DE (ed). American Society of Health System Pharmacists. Bethesda, MD. 2016: 97-107.

Selected Peer-Reviewed Journal Publications

  • Faine B, Spolsdoff DE, Negaard BJ, Lewis A, Santiago R, Krenz J, Feldman R, Slocum G, Howington G, Sarangarm P, Mattson A, Brown C, Zepeski A, Rech MA, Koehl J, Zimmerman DE. Cephalosporins for Outpatient PYelonephritis in the Emergency Department: COPY-ED Study - on behalf of EMPHARM-NET Investigators. Annals of Emergency Medicine. 2025;85(3):240-8.
  • Koehl J, Brown CS, Faine B, Rech MA, Zimmerman DE, Flack T, Gilbert BW, Howington GT, Laub J, Porter B, Slocum GW, Zepeski A, Feldman R, Santiago RD, Saranagarm P. Educated: the emergency medicine pharmacotherapy literature of 2023. Am J Emerg Med. 2024;82:166-72.
  • Ray L, Acquisto NA, Coralic Z, Feldman R, Mercer K, Zimmerman DE, Howington GT, Slocum GW, Faine B, Rech MA. A national survey of medication utilization for cardiac resuscitation in the emergency department: a survey of emergency medicine pharmacists. Am J Health-Syst Pharm. 
  • Rech M, Faine B, Gross A, Vakkalaka JP, Brown C, Harding S, Slocum G, Zimmerman DE, Zepeski A, Rewitzer S, Howington G, Campbell M, Dawson J, Treu C, Nelson L, Jones M, Flack T, Porter B, Sarangarm P, Matson A, Bailey A, Kelly G, Talan D. Empiric Antimicrobial Prescribing for Pyelonephritis in Patients Discharged from 15 U.S. Emergency Departments: An Opportunity for Improvement. Journal of Antimicrobial Chemotherapy. 2024;79:1038-44.
  • Zimmerman DE, Johnson B, Kearns A, Metro H, Robb A, Nemecek BD, Montepara CA, Covvey JR, Lynch MJ. The use of buprenorphine to-go packs in the emergency department.Am J Emerg Med. 2024;77:154-77.
  • Montepara CA, Bortmas MR, Cochenour CJ, Fleming MK, Gaffey SH, McQuigg MA, Parisi MK, Zimmerman DE, Covvey JR, Nemecek BD. The effect of potassium supplementation and concomitant medications on potassium homeostasis for hospitalized patients. Am J Health-Syst Pharm. 2024;81(6):183-9.
  • Manspeaker SA, Deluliis ED, Delehanty AD, McCann M, Zimmerman DE, O’Neil C, Shaffer J, Crytzer TM, Loughran MC. Impact of a Grand Rounds Interprofessional Workshop: Student Perceptions of Interprofessional Socialization and Cultural Humility. Journal of Interprofessional Care. 2024;38(3):460-8.
  • Zimmerman DE, Tomas M, Miller D, Tomcsanyi L, Signorella C, Montepara CM, Covvey JR, Guarascio AJ. Cephalosporins for the treatment of uncomplicated pyelonephritis: a systematic review. J Am Pharm Assoc. 2023;63(5):1461-71.
  • Sarrangarm P, Zimmerman DE, Faine B, Rech MA, Flack T, Gilbert BW, Howington GT, Laub J, Porter B, Slocum GW, Zepeski A, Brown CS. UpdatED: The emergency medicine pharmacotherapy literature of 2022. Am J Emerg Med. 2023;69:136-42.
  • Gregory H, Aljadeed R, Desai D, Minhaj FS, Posen A, Rech MA, Smith AS, Weant K, Won K, Zimmerman DE. Recommendations for nonantidote medications needed in the emergency department during a mass casualty incident. Am J Health-Syst Pharm. 2023;80(12):779-85.
  • Chun H, Zimmerman DE, Covvey JR, Nemecek BD. Initiation of oral antihypertensives in hospitalized patients with hypertensive urgency: a descriptive study. Am J Health-Syst Pharm. 2023;80(supp 3):S85-96.
  • Faine BA, Rech MA, Vakkalanka P, Gross A, Brown C, Harding SJ, Slocum G, Zimmerman DE, Zepeski A, Rewitzer S, Howington GT, Campbell M, Dawson J, Treu CN, Nelson L, Jones M, Flack T, Porter B, Sarangarm P, Mattson AE, Bailey AB, Kelly G, Talan D. High prevalence of fluroquinolone-resistant UTI among US emergency department patients diagnosed with urinary tract infection, 2018-2020. Acad Emerg Med. 2022;29:1096-1105.
  • Brown CS, Sarangarm P, Faine B, Rech MA, Flack T, Gilbert BW, Howington GT, Kelly G, Laub J, Porter BA, Slocum GW, Zepeski A, Zimmerman DE. A year ReviewED: Top emergency medicine pharmacotherapy articles of 2021. Am J Emerg Med. 2022; 60:88-95.
  • Ball NS, Knable BM, Relich TA, Smathers AN, Gionfriddo MR, Nemecek BD, Montepara CM, Guarascio AJ, Covvey JR, Zimmerman DE. Xylazine poisoning: a systematic review. Clin Toxicol. 2022 April 19:1-4. DOI
  • Babdihan R, Lewis A, Atkins C, Jozefczyk N, Nemecek BD, Montepara CA, Gionfriddo MR, Zimmerman DE, Covvey JR, Guarascio AJ. Safety and efficacy of cefiderocol for off-label treatment indications: a systematic review. Pharmacotherapy. 2022;42(7):549-66.
  • PHBM 431: Psych Neuro
  • PHBM 443 Therapeutics Across the Lifespan
  • PHBM 444: Therapeutics in the Critically Ill
  • PHPR 493/4: Acute Care 1 and 2
  • PHPR 341: Pharmacy Practice 1
  • PHPR 448: Drug Literature Evaluation